ATE235252T1 - Methode zur verminderung arterieller stenose - Google Patents

Methode zur verminderung arterieller stenose

Info

Publication number
ATE235252T1
ATE235252T1 AT95925386T AT95925386T ATE235252T1 AT E235252 T1 ATE235252 T1 AT E235252T1 AT 95925386 T AT95925386 T AT 95925386T AT 95925386 T AT95925386 T AT 95925386T AT E235252 T1 ATE235252 T1 AT E235252T1
Authority
AT
Austria
Prior art keywords
tfpi
arterial stenosis
hours
balloon angioplasty
reducing arterial
Prior art date
Application number
AT95925386T
Other languages
English (en)
Inventor
D Abendschein
Avenue Euclid
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE235252T1 publication Critical patent/ATE235252T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Devices For Medical Bathing And Washing (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
  • Excavating Of Shafts Or Tunnels (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT95925386T 1994-07-07 1995-07-06 Methode zur verminderung arterieller stenose ATE235252T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27193094A 1994-07-07 1994-07-07
PCT/US1995/008221 WO1996001649A1 (en) 1994-07-07 1995-07-06 Method of attenuating arterial stenosis

Publications (1)

Publication Number Publication Date
ATE235252T1 true ATE235252T1 (de) 2003-04-15

Family

ID=23037681

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95925386T ATE235252T1 (de) 1994-07-07 1995-07-06 Methode zur verminderung arterieller stenose

Country Status (10)

Country Link
EP (1) EP0769962B1 (de)
JP (2) JP4065557B2 (de)
AT (1) ATE235252T1 (de)
AU (1) AU2953795A (de)
CA (1) CA2194443A1 (de)
DE (1) DE69530084T2 (de)
DK (1) DK0769962T3 (de)
ES (1) ES2196067T3 (de)
PT (1) PT769962E (de)
WO (1) WO1996001649A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
WO1996040784A2 (en) 1995-06-07 1996-12-19 Chiron Corporation Method of solubilizing, purifying, and refolding protein
EP1654283B1 (de) 2003-08-13 2011-07-13 Novartis Vaccines and Diagnostics, Inc. Verbessertes verfahren zur reinigung von tfpi und tfpi-analogen
KR101612130B1 (ko) * 2007-03-20 2016-04-12 이데미쓰 고산 가부시키가이샤 스퍼터링 타겟, 산화물 반도체막 및 반도체 디바이스

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0465557A (ja) * 1990-06-28 1992-03-02 Unitika Ltd 起毛編物の製造方法
EP0473564B1 (de) * 1990-08-27 1996-03-20 Monsanto Company Anticoagulatorische Zusammensetzung aus LACI und sulfatierten Polysacchariden
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
AU4408493A (en) * 1992-06-11 1994-01-04 Washington University Prophylaxis and treatment of sepsis and sepsis-associated coagulation disorders

Also Published As

Publication number Publication date
DE69530084T2 (de) 2004-02-05
WO1996001649A1 (en) 1996-01-25
DK0769962T3 (da) 2003-06-23
AU2953795A (en) 1996-02-09
EP0769962B1 (de) 2003-03-26
PT769962E (pt) 2003-07-31
ES2196067T3 (es) 2003-12-16
JPH10502639A (ja) 1998-03-10
JP4065557B2 (ja) 2008-03-26
JP2008007512A (ja) 2008-01-17
EP0769962A1 (de) 1997-05-02
DE69530084D1 (de) 2003-04-30
CA2194443A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
CA2238098A1 (en) Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis
HUT72317A (en) Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence
UA84665C2 (ru) Способ ингибирования опосредствованного ангиогенеза в ткани у пациента с неоваскулярным заболеванием роговицы
UA43391C2 (uk) Спосіб інгібування міжклітинного зчеплення і спосіб інгібування запального процесу та порушеного процесу нормальної коагуляції у пацієнтів з розладами васкулярного ендотелію
CA2285389A1 (en) Use of cytoskeletal inhibitors for the prevention of restenosis
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
ZA962275B (en) Carboxyalkylethers formulations and treatment of vascular diseases
BG104316A (en) Tetrazolecontaining analogues of rapamycin, having reduced period of semidecomposition
AU6286294A (en) Guanidine derivatives useful in therapy
DE69327263D1 (de) Verwendung des Gewebefaktor-Inhibitors zur Herstellung eines Arzneimittels gegen Mikrogefässthrombose
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
LV11728A (lv) Farmaceitiska kompozicija
DE69530084D1 (de) Methode zur verminderung arterieller stenose
ES2108595A1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
WO2003045311A3 (en) Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
WO1994005296A3 (en) Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
GR3021171T3 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0437025A3 (en) Compositions containing aldose reductase inhibitors for the treatment of ulcers
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0769962

Country of ref document: EP

REN Ceased due to non-payment of the annual fee